Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis.

De Luca C, Sgariglia R, Nacchio M, Pisapia P, Migliatico I, Clery E, Gragnano G, Campione S, Vigliar E, Malapelle U, De Dominicis G, Bellevicine C, Troncone G.

Diagn Cytopathol. 2020 Jan 6. doi: 10.1002/dc.24378. [Epub ahead of print]


Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.

Bellevicine C, Migliatico I, Sgariglia R, Nacchio M, Vigliar E, Pisapia P, Iaccarino A, Bruzzese D, Fonderico F, Salvatore D, Biondi B, Masone S, Novizio V, Scavuzzo F, Serino D, De Palma M, Chiofalo MG, Botti G, Pezzullo L, Nuzzo V, Spiezia S, De Chiara G, Iorio S, Conzo G, Docimo G, Faggiano A, Bongiovanni M, Malapelle U, Colao A, Triassi M, Troncone G; Tiroide Network.

Cancer Cytopathol. 2019 Dec 10. doi: 10.1002/cncy.22217. [Epub ahead of print]


Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples.

Pepe F, De Luca C, Smeraglio R, Pisapia P, Sgariglia R, Nacchio M, Russo M, Serra N, Rocco D, Battiloro C, Ambrosio F, Gragnano G, Vigliar E, Bellevicine C, Troncone G, Malapelle U.

J Clin Pathol. 2019 Jan;72(1):38-45. doi: 10.1136/jclinpath-2018-205386. Epub 2018 Oct 2.


Prevalence of proximal ascending aorta and target organ damage in hypertensive patients: the multicentric ARGO-SIIA project (Aortic RemodellinG in hypertensiOn of the Italian Society of Hypertension).

Milan A, Degli Esposti D, Salvetti M, Izzo R, Moreo A, Pucci G, Bruno G, Pareo I, Parini A, Paini A, Laurino FI, Sormani P, Sgariglia R, Avenatti E, De Luca N; Working Group on Heart and Hypertension of the Italian Society of Hypertension.

J Hypertens. 2019 Jan;37(1):57-64. doi: 10.1097/HJH.0000000000001844.


Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.

Bellevicine C, Sgariglia R, Migliatico I, Vigliar E, D'Anna M, Nacchio MA, Serra N, Malapelle U, Bongiovanni M, Troncone G.

Cancer Cytopathol. 2018 May;126(5):317-325. doi: 10.1002/cncy.21984. Epub 2018 Feb 22.


Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting.

Pisapia P, Pepe F, Smeraglio R, Russo M, Rocco D, Sgariglia R, Nacchio M, De Luca C, Vigliar E, Bellevicine C, Troncone G, Malapelle U.

J Thorac Dis. 2017 Oct;9(Suppl 13):S1383-S1390. doi: 10.21037/jtd.2017.06.97.


Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study.

Sgariglia R, Pisapia P, Nacchio M, De Luca C, Pepe F, Russo M, Bellevicine C, Troncone G, Malapelle U.

J Clin Pathol. 2017 Sep;70(9):803-806. doi: 10.1136/jclinpath-2017-204373. Epub 2017 Apr 6.


Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.

Malapelle U, Mayo de-Las-Casas C, Rocco D, Garzon M, Pisapia P, Jordana-Ariza N, Russo M, Sgariglia R, De Luca C, Pepe F, Martinez-Bueno A, Morales-Espinosa D, González-Cao M, Karachaliou N, Viteri Ramirez S, Bellevicine C, Molina-Vila MA, Rosell R, Troncone G.

Br J Cancer. 2017 Mar 14;116(6):802-810. doi: 10.1038/bjc.2017.8. Epub 2017 Feb 7.


Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?

Bellevicine C, Sgariglia R, Malapelle U, Vigliar E, Nacchio M, Ciancia G, Eszlinger M, Paschke R, Troncone G.

Cancer Cytopathol. 2016 Nov;124(11):776-784. doi: 10.1002/cncy.21780. Epub 2016 Sep 26.


Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.

Malapelle U, Pisapia P, Sgariglia R, Vigliar E, Biglietto M, Carlomagno C, Giuffrè G, Bellevicine C, Troncone G.

J Clin Pathol. 2016 Sep;69(9):767-71. doi: 10.1136/jclinpath-2015-203403. Epub 2016 Jan 21.


EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer.

Malapelle U, Vatrano S, Russo S, Bellevicine C, de Luca C, Sgariglia R, Rocco D, de Pietro L, Riccardi F, Gobbini E, Righi L, Troncone G.

J Clin Pathol. 2015 Sep;68(9):739-41. doi: 10.1136/jclinpath-2015-203101. Epub 2015 Jun 5.


UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.

Cacciola NA, Calabrese C, Malapelle U, Pellino G, De Stefano A, Sepe R, Sgariglia R, Quintavalle C, Federico A, Bianco A, Uchimura Bastos A, Milone M, Bellevicine C, Milone F, Carlomagno C, Selvaggi F, Troncone G, Fusco A, Pallante P.

Mol Carcinog. 2016 May;55(5):793-807. doi: 10.1002/mc.22322. Epub 2015 Apr 27.


KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer.

Malapelle U, Sgariglia R, De Stefano A, Bellevicine C, Vigliar E, de Biase D, Sepe R, Pallante P, Carlomagno C, Tallini G, Troncone G.

J Clin Pathol. 2015 Apr;68(4):265-9. doi: 10.1136/jclinpath-2014-202761. Epub 2015 Jan 21.


Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.

Malapelle U, Vigliar E, Sgariglia R, Bellevicine C, Colarossi L, Vitale D, Pallante P, Troncone G.

J Clin Pathol. 2015 Jan;68(1):64-8. doi: 10.1136/jclinpath-2014-202691. Epub 2014 Nov 5.


EGFR mutation detection by microfluidic technology: a validation study.

Malapelle U, Russo S, Pepe F, Sgariglia R, De Luca C, Bellevicine C, Pallante P, Troncone G.

J Clin Pathol. 2013 Nov;66(11):982-4. doi: 10.1136/jclinpath-2013-201730. Epub 2013 Jun 21.


Supplemental Content

Loading ...
Support Center